Myoview 30ml

   
Google
 
Web NewDrugInformation.com

Myoview 30ml


Drug - Myoview 30ml
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Technetium Tc-99m Tetrofosmin Kit
Multiple ingredients are in alphabetical order.

Strength - N/A
The potency of the active ingredient(s), Technetium Tc-99m Tetrofosmin Kit. May repeat for multiple part products.

Applicant - GE HEALTHCARE
The firm name holding legal responsibility for Myoview 30ml. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 020372
The FDA assigned number to Myoview 30ml. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Myoview 30ml. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jul 7, 2005
The date Myoview 30ml was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Myoview 30ml. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Myoview 30ml is in. Format is RX, OTC, DISCN.

Applicant Full Name - Ge Healthcare
The full name of the firm holding legal responsibility for the new application of Myoview 30ml.

Myoview 30ml